Related Experiment Videos
Conjunctival ulceration following triamcinolone injection.
Shishir Agrawal1, Jaya Agrawal, Trilok Prakash Agrawal
1T. P. Agrawal Institute of Ophthalmology, Meerut, India. dr_shishir@vsnl.com
American Journal of Ophthalmology
|September 12, 2003
Summary
Periocular triamcinolone acetonide injections can lead to conjunctival ulceration. This complication, observed in three patients, typically resolves with minimal scarring after corticosteroid extrusion.
Area of Science:
- Ophthalmology
- Dermatology
Background:
- Corticosteroids like triamcinolone acetonide are frequently used for periocular conditions.
- Periocular injections aim to deliver medication directly to the target area.
Observation:
- Three patients developed conjunctival ulceration following periocular triamcinolone acetonide injections.
- The triamcinolone acetonide was deposited in the subtenon's or subconjunctival space.
- Cultures from the ulcer edges were negative, suggesting a non-infectious etiology.
Findings:
- Conjunctival ulceration is a potential complication of periocular triamcinolone acetonide administration.
- The majority of the injected triamcinolone extruded from the site.
- The conjunctival ulcers healed with minimal scarring in the observed cases.
Implications:
- Clinicians should be aware of conjunctival ulceration as a possible adverse event.
- Careful injection technique may be necessary to minimize this risk.
- Understanding this complication aids in patient counseling and management.